Compare TG Therapeutics Inc (TGTX) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Unilever plc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Unilever plc trades at $62.18 (market cap $131.86B). The key difference: Unilever plc is far larger — about 16× TG Therapeutics Inc's market cap, and Unilever plc pays a 3.68% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | UL | |
|---|---|---|
Market Cap | $8.26B | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $59.06 | $74.59 |
52-Week Low | $26.39 | $55.05 |
Enterprise Value | $8.50B | $157.31B |
Dividend Yield | — | 3.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
